AKT1 and lung carcinoma: Cao et al. reported that miR-365 inhibited growth, invasion and metastasis of lung cancer by targeting NRP1 expression31, and Tong et al. showed that miR-365 inhibited the progression of lung adenocarcinoma through targeting ETS1 and inactivating AKT/mTOR pathway32.